Predictors of mortality in cardiac surgery: brain natriuretic peptide type B

Jamil Alli Murad Junior1, Marcelo Arruda Nakazone1, Mauricio de Nassau Machado1

  • 1Hospital de Base, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil.

Insights

Preoperative brain natriuretic peptide (BNP) levels predict mortality in cardiac surgery patients. Elevated BNP greater than 382 pg/mL independently indicates a higher risk of 30-day mortality after valve or coronary artery bypass grafting surgery.

Area of Science:

  • Cardiology
  • Biomarkers
  • Surgical Outcomes

Background:

  • Cardiac surgery, including valve replacement and coronary artery bypass grafting (CABG), carries inherent risks.
  • Predicting postoperative mortality is crucial for patient management and risk stratification.

Purpose of the Study:

  • To determine if preoperative serum brain natriuretic peptide (BNP) concentration predicts in-hospital mortality in patients undergoing cardiac surgery.

Main Methods:

  • A prospective study evaluated 488 patients undergoing cardiac valve surgery or CABG between 2009 and 2012.
  • Patients were followed for 30 days postoperatively.
  • Receiver Operating Characteristic (ROC) curve and multivariate analyses were performed.

Main Results:

  • The overall mortality rate was 9.6%.
  • An optimal BNP cutoff of 382 pg/mL for predicting mortality was identified (AUC=0.73).
  • Preoperative BNP > 382 pg/mL was an independent predictor of 30-day mortality (P=0.033, HR=2.05).

Conclusions:

  • Preoperative serum BNP concentration is a significant independent predictor of mortality in patients undergoing valve surgery or CABG.
  • BNP serves as a valuable biomarker for risk assessment in cardiac surgical patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
773
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
435
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
589
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K